Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration
Description of the granted funding
The delivery of therapeutic agents to the central nervous system remains a major challenge. This is especially true in neurodegenerative diseases. While significant discoveries have recently been made in the genetics of ALS/FTD, patients still have no real therapeutic treatments. Here we aim to boost the clinical translation of the preclinical research and assembled a multidisciplinary research team with complimentary expertise to (1) generate 3D in vitro multicellular organoid models from iPSCs derived from healthy and patients with ALS/FTD; (2) fully characterize the newly generated models using established assays in the consortium (e.g. molecular markers and electrophysiology); (3) explore mechanistic pathways in particular pro-inflammatory, anti-oxidant and DNA damage pathways and ultimately use the model for (4) drug and gene based therapeutic screening.
Show moreStarting year
2020
End year
2023
Granted funding
Funder
Research Council of Finland
Funding instrument
Kansainvälinen yhteisrahoitteinen ohjelma
Other information
Funding decision number
334801
Fields of science
Neurosciences
Research fields
Neurotiede
Identified topics
brain, neuroscience